Contributions of LabRangeLindy
User contributions·23 logged edits·page 1 of 1
Contributions by LabRangeLindy, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 1,877 edits includes activity predating the current log.
- 09:48, 30 Jun 2026 (diff | hist) Talk:Cold chain 1,718 +103 /* Domestic refrigerator claim: which studies? */ reply
- 14:05, 18 Jun 2026 (diff | hist) Talk:Baseline laboratory panel 748 +117 /* Regression to the mean */ reply
- 22:07, 14 Jun 2026 (diff | hist) C-peptide 4,400 ±0 rm the diagnostic threshold — the article describes, it does not diagnose
- 14:05, 28 May 2026 (diff | hist) Talk:FLOW trial 748 +126 /* The initial eGFR dip */ reply
- 14:22, 19 May 2026 (diff | hist) Talk:Cold chain 1,085 +344 /* Domestic refrigerator claim: which studies? */ new section
- 10:20, 17 May 2026 (diff | hist) Talk:Fasting insulin 537 +114 /* Assay-specific cut-offs */ new section
- 08:44, 10 May 2026 (diff | hist) Prescribing information 4,506 ±0 add the currency and the date to every price figure
- 14:38, 14 Apr 2026 (diff | hist) Fasting insulin 4,198 ±0 m British spelling per PP:MOS
- 13:20, 3 Feb 2026 (diff | hist) Talk:Haemoglobin A1c 611 +103 /* Weighting towards recent weeks */ reply
- 18:51, 15 Oct 2025 (diff | hist) Karl Fischer titration 9,318 ±0 add the plate-count expression and define its terms
- 06:49, 21 Aug 2025 (diff | hist) Patent expiry and biosimilars 4,183 ±0 m clarify that personal importation and commercial importation are different questions
- 09:54, 19 Aug 2025 (diff | hist) Hypoglycaemia 4,417 ±0 m add the note that titration exists partly to manage these effects
- 07:30, 3 May 2025 (diff | hist) Xi'an Mokemei Biotechnology 5,092 +335 m state the city and province of the registered address
- 23:15, 26 Mar 2025 (diff | hist) Liquid chromatography-mass spectrometry 3,724 +273 m add the reference standard and its traceability
- 09:01, 22 Jan 2025 (diff | hist) Active pharmaceutical ingredient 2,832 ±0 state that research-use-only labelling is a commercial category, not an approval
- 20:59, 16 Jan 2025 (diff | hist) Beta cell function 4,328 +92 m expand §What is being measured
- 04:16, 17 Dec 2024 (diff | hist) GLP-1 receptor 5,522 +335 the glucose-dependence of the insulinotropic effect deserves its own sentence
- 11:25, 16 Dec 2024 (diff | hist) LEADER trial 3,133 +776 correct the baseline mean — transposed digits
- 04:18, 25 Nov 2024 (diff | hist) CagriSema 2,861 +600 m add the structural figure and caption it properly
- 10:14, 21 Nov 2024 (diff | hist) C-peptide 2,537 ±0 m fix indentation in the source
- 18:04, 14 Oct 2024 (diff | hist) Satiety signalling 3,234 +488 correct the second-messenger pathway named in the lead
- 07:49, 5 Oct 2024 (diff | hist) HOMA-IR 1,590 +177 add the body-composition measurement method to the comparison
- 09:00, 4 Aug 2024 (diff | hist) Subcutaneous injection 1,450 +1,450 N new article: dosing and handling, expansion welcome